Rating Change
Barclays analysts initiated coverage on Edwards Lifesciences Corporation (NYSE:EW) with a rating of Overweight on October 07, 2026.
new coverageNYSE:EW
Barclays Initiates Coverage on Edwards Lifesciences Corporation (EW) with Overweight
Barclays analysts initiated coverage on Edwards Lifesciences Corporation (NYSE:EW) with a rating of Overweight on October 07, 2026.
At publication ·
What changed
Edwards Lifesciences Corporation (NYSE:EW) · new coverage
- Firm
- Barclays
- Rating
- Overweight
- Price at event
- $86.28
- Market capitalization
- $49.5B
At a glance
Key takeaways
- Barclays initiated coverage of Edwards Lifesciences on October 7, 2026 with an Overweight rating.
- Edwards Lifesciences trades at $86.28 with a $49.5B market capitalization and gained 0.8% over the past 52 weeks.
Market Context
Edwards Lifesciences Corporation operates in the Healthcare sector. The stock currently trades at $86.28 with a market capitalization of $49.5B. The stock has gained 0.8% over the past 52 weeks.
Analyst coverage from Barclays provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Edwards Lifesciences Corporation.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Edwards Lifesciences Corporation
Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 07, 2026 | Barclays | Overweight | N/A |
| Sep 11, 2026 | BTIG | Buy | N/A |
| Jul 24, 2026 | Leerink Partners | Outperform | N/A |
| Jul 24, 2026 | Piper Sandler | Overweight | N/A |
| Jul 24, 2026 | JP Morgan | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View EW Stock Page
Frequently Asked Questions
What does the Overweight rating mean for EW?
A rating of Overweight from Barclays reflects the analyst's outlook on Edwards Lifesciences Corporation (NYSE:EW). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the EW forecast page.
